Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Luqa Acquires China Rights to Three BMG Pharma Products

publication date: Jul 12, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Luqa Pharma has partnered with BMG Pharma S.r.l. of Italy to bring BMG’s products to China. Luqa will be responsible for registering and commercializing BMG’s dermatology, oral care and cancer support therapy products in mainland China and Hong Kong. Luqa, headquartered in Hong Kong, acquires innovative niche products for unmet needs in the China market. More details....

Share this with colleagues:  

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...